Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Completed

Conditions studied: Gastric Ultrasound, Glucagon-like Peptide 1, Point of Care Ultrasound

In brief

The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists.

Key facts

Study ID: NCT06003985
Run by: Hospital for Special Surgery, New York
People needed: 354
Starts: 2023-08-29
Expected to finish: 2025-02-01
Last updated by the study team: 2025-11-26

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

GLP 1 patient group: any patient on GLP1 agonists that are dosed once per week (semaglutide, dulaglutide, tirzepatide), for all indications.
Control group (No GLP 1 patients): any patient not on GLP1 agonists that are dosed once per week, for all indications.

You may not qualify if…

patient refusal to participate
patients with gastric bypass or any other gastric surgery
large hiatal hernia
patients with large ascites
patients on peritoneal dialysis
emergency surgery
pre-existing diagnosis of gastroparesis

Where it is running

George Washington University Hospital — Washington D.C., District of Columbia, United States
Mayo Clinic — Jacksonville, Florida, United States
Albany Medical Center — Albany, New York, United States
Hospital for Special Surgery — New York, New York, United States
Memorial Sloan Kettering Cancer Center — New York, New York, United States
Weill Cornell Medicine — New York, New York, United States
University of Virginia — Charlottesville, Virginia, United States
University Health Network — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.